secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001104659-24-070847
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 2024 Equity Incentive Plan adding 2.1M shares; all director nominees elected
--------------------------------------------------------------------------------

- All nine director nominees elected at June 12 annual meeting; quorum of 75.6%.
- 2024 Equity Incentive Plan approved (37.1M for); authorizes 2.1M new shares, replacing 2015 Plan.
- Advisory 'say-on-pay' passed (37.3M for); Ernst & Young ratified as auditor for FY 2024.
- Charter amendment adding officer exculpation provisions approved.
- Plan effective Feb 28, 2024; no changes to executive compensation or board composition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924070847/0001104659-24-070847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924070847/tm2416687d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-070847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer